Libertae Revenue and Competitors
Estimated Revenue & Valuation
- Libertae's estimated annual revenue is currently $7.3M per year.
- Libertae's estimated revenue per employee is $216,000
Employee Data
- Libertae has 34 Employees.
- Libertae grew their employee count by -8% last year.
Libertae's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Program Manager | Reveal Email/Phone |
3 | Music Therapist | Reveal Email/Phone |
Libertae Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $14.8M | 61 | -3% | N/A | N/A |
#2 | $14.1M | 58 | 12% | N/A | N/A |
#3 | $468M | 1238 | 9% | N/A | N/A |
#4 | $9.7M | 45 | 2% | N/A | N/A |
#5 | $4M | 21 | 62% | N/A | N/A |
#6 | $6.5M | 30 | 0% | N/A | N/A |
#7 | $14.8M | 61 | 13% | N/A | N/A |
#8 | $62.1M | 209 | 3% | N/A | N/A |
#9 | $8.4M | 39 | 11% | N/A | N/A |
#10 | $33.5M | 124 | 1% | N/A | N/A |
What Is Libertae?
Libertae is a four to seven month residential treatment program for women with up to three children respectively. It is the mission of Libertae to empower women and their families to maintain recovery through comprehensive treatment programs that support healthy communities. Our gender responsive and trauma-focused programs utilize evidence based treatment approaches and the 12-step philosophies in a holistic model. Libertae shall ensure the availability of preferential treatment to pregnant women. Priority is given to women as follows: (a) pregnant injection-drug users; (b) pregnant substance users; (c) injection-drug users; and (d) all others. Libertae is a proud partner of the Bucks County Women’s Advocacy Coalition.
keywords:N/AN/A
Total Funding
34
Number of Employees
$7.3M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.9M | 34 | 10% | N/A |
#2 | $7.9M | 34 | 10% | N/A |
#3 | $8.1M | 35 | -8% | N/A |
#4 | $9.2M | 36 | 3% | N/A |
#5 | $9.8M | 37 | 6% | N/A |